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Background: Arthritis gloves are provided by NHS rheumatology occupational therapists 
(OTs) to people with inflammatory arthritis (IA) to reduce hand pain and stiffness and 
improve hand function. However, there is little evidence to support their effectiveness or 
efficacy. We are conducting a NIHR Research for Patient Benefit (PB-PG-0214-33010) 
funded multi-centre national randomized controlled trial (RCT) testing the efficacy of 
arthritis gloves in people with IA. Twenty-seven Rheumatology OTs from (Band 6) from 17 
NHS Trusts across the UK are treating trial participants. As part of their trial training, we 
explored OTs’ views about contributing to the RCT, to identify any concerns and ongoing 
training needs in trial delivery.  
 
Methods: Three focus groups (FGs), using a semi-structured interview schedule were 
conducted. The Rheumatology OTs collaborating in the trial attended a one-day clinical trial 
training programme which included trial background, key study procedures and practize 
providing the intervention and placebo gloves in a standardized manner using the OT Glove 
Provision Manual. Informed written consent was obtained from all participants and FGs were 
audio recorded, transcribed verbatim and analysed by two researchers independently using 
Thematic Analysis to increase the confirmability of the findings.  
 
Results: The main challenges identified by OTs were themed around Personal, Service and 
Research Methodology Factors. Personal Factors included: trepidations about being involved 
in a RCT; and concerns around delivering a placebo treatment to patients with hand pain and 
stiffness. Service Factors included: being able to recruit to target within service constraints; 
receiving support from their consultants and research staff; and whether they could treat 
participants within the given time frame. Research Methodology Factors included: risk of 
introducing bias when delivering a placebo treatment, due to concerns about going against 
participants’ best interests, or lack of experience addressing participants’ queries without 
revealing treatment allocation. However, they also perceived opportunities from being 
involved in a multi-centred RCT. These were Professional Development and evidence-based 
practice opportunities such as; potential to improve relationships within their multi-
disciplinary teams, widen their professional networks, and raise the profile of OT by 
contributing to evidence-based practice. Most OTs acknowledged that their trepidations were 
related to inexperience and expected to become more confident following training, 
familiarization with study protocols and delivery of their first placebo treatment.  
 
Conclusion: This trial is one of the few UK-funded placebo-controlled trials examining the 
clinical efficacy of OT intervention in rheumatology services. This introduces new issues for 
clinicians in knowingly delivering placebo interventions as part of a RCT. Our OTs identify 
personal, service and research factors that cause them trepidation in taking part but also 
recognize clear professional development opportunities in contributing to evidence-based 
practice 
 
